Research programme: KDR inhibitors - Amgen
Latest Information Update: 22 Mar 2010
At a glance
- Originator Amgen
- Class Amides; Naphthalenes; Quinolines
- Mechanism of Action Vascular endothelial growth factor receptor-2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 08 Sep 2008 Preclinical development is ongoing in USA
- 27 Apr 2006 Preclinical trials in Cancer in USA (RO)